Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain
- 1 September 2002
- journal article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 7 (8) , 845-850
- https://doi.org/10.1038/sj.mp.4001111
Abstract
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatmentKeywords
This publication has 49 references indexed in Scilit:
- Molecular Targets of Lithium ActionAnnual Review of Pharmacology and Toxicology, 2001
- Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitroMolecular Psychiatry, 2001
- Prostaglandin E (EP) receptor subtypes and sleepNeuroReport, 2000
- Molecular mechanisms of sleep–wake regulation: a role of prostaglandin D 2Philosophical Transactions Of The Royal Society B-Biological Sciences, 2000
- Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorderMolecular Psychiatry, 1999
- Prostaglandin Synthase-1 and Prostaglandin Synthase-2 Are Coupled to Distinct Phospholipases for the Generation of Prostaglandin D2 in Activated Mast CellsJournal of Biological Chemistry, 1997
- Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitorBrain Research, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorderPsychiatric Genetics, 1995
- A biochemical basis for the actions of lithium on behaviour and on immunity: Relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune systemMedical Hypotheses, 1981